Archive

Latest California Healthline Stories

Trump Administration Investigates Medicaid Spending on Immigrants in Blue States

The Centers for Medicare & Medicaid Services is hunting for Medicaid waste, fraud, and abuse in at least six Democratic-led states that expanded coverage to low-income and disabled immigrants without legal status, according to records obtained by KFF Health News and The Associated Press.

Listen: Limiting Benefits and Adding Restrictions, ‘MAHA’ Reshapes Food Aid

The White House and congressional Republicans have made historic changes to the federal anti-hunger program SNAP. They say the changes will boost healthy eating for low-income Americans. Some nutrition experts aren’t so sure.

As Insurers Struggle With GLP-1 Drug Costs, Some Seek To Wean Patients Off

Conventional wisdom says GLP-1 drugs must be taken indefinitely to maintain weight loss. But a growing number of researchers, payers, and providers are challenging that consensus and exploring whether — and how — to taper patients off expensive GLP-1 drugs.

Do Pediatricians Recommend Vaccines To Make a Profit? There’s Not Much Money in It

Four pediatricians said evidence-based science and medicine and a desire to keep kids healthy drive doctors’ childhood vaccination recommendations. And while pediatric practices might make money immunizing privately insured children, most practices likely break even or lose money from providing the shots.

Changes at NIH Give Political Appointees Greater Power To Fund or Block Research

The National Institutes of Health’s long-held standard of peer review for grantmaking has been subverted by President Donald Trump and NIH Director Jay Bhattacharya, who gave unprecedented power to politicos, NIH workers say.

At CDC, Worries Mount That Agency Has Taken Anti-Science Turn

Health and Human Services Secretary Robert F. Kennedy Jr.’s push to fire Centers for Disease Control and Prevention Director Susan Monarez is more than an administrative shake-up. It marks a major offensive by Kennedy to seize control of the agency and impose an anti-science agenda, public health leaders say.